JOHNSON & JOHNSON

Holdings History for Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

Symbol: RAPP on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Shares Owned: 1,784,517 shares
Security Ownership %: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

JOHNSON & JOHNSON ownership in Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP)

22 Oct 2025 - JOHNSON & JOHNSON has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,784,517 shares of Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP). This represents 4.9% ownership of the company. This is the first filing by JOHNSON & JOHNSON disclosing ownership of Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
JOHNSON & JOHNSON	4.9%		$53,000,690	1,784,517			$29.70	13G/A	30 Sep 2025	22 Oct 2025, 17:09

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	9.8%	0%	$54,142,246	1,784,517	0		$30.34	Q4 2025
30 Sep 2025	11%	-4.2%	$53,000,155	1,784,517	-713,534	-29%	$29.70	Q3 2025
30 Jun 2025	8.5%	0%	$28,552,723	2,498,051	0		$11.43	Q2 2025
31 Mar 2025	7.3%	0%	$25,055,452	2,498,051	0		$10.03	Q1 2025
31 Dec 2024	11%	0%	$44,315,425	2,498,051	0		$17.74	Q4 2024
30 Sep 2024	12%	0%	$51,160,084	2,498,051	0		$20.48	Q3 2024
30 Jun 2024	15%	+1.3%	$58,104,666	2,498,051	+2,498,051	NEW	$23.26	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.